Anixa Biosciences (ANIX)
(Delayed Data from NSDQ)
$3.05 USD
+0.16 (5.54%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $3.06 +0.01 (0.33%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth B Momentum F VGM
Brokerage Reports
0 items in cart
ANIXA BIOSCIENCES INC [ANIX]
Reports for Purchase
Showing records 21 - 36 ( 36 total )
Company: ANIXA BIOSCIENCES INC
Industry: Business - Services
Ovarian Cancer CAR-T Trial Initiated; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: ANIXA BIOSCIENCES INC
Industry: Business - Services
Company: ANIXA BIOSCIENCES INC
Industry: Business - Services
New Patent Granted for Ovarian Cancer Vaccine; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: ANIXA BIOSCIENCES INC
Industry: Business - Services
Breast Cancer Vaccine Trial Starts Patient Dosing; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: ANIXA BIOSCIENCES INC
Industry: Business - Services
CAR-T Therapy Chinese Patent Granted; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: ANIXA BIOSCIENCES INC
Industry: Business - Services
Breast Cancer Vaccine Trial Commences; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: ANIXA BIOSCIENCES INC
Industry: Business - Services
Company: ANIXA BIOSCIENCES INC
Industry: Business - Services
Company: ANIXA BIOSCIENCES INC
Industry: Business - Services
Company: ANIXA BIOSCIENCES INC
Industry: Business - Services
FDA Clears Investigational New Drug Application for CAR-T Therapy; Reit Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: ANIXA BIOSCIENCES INC
Industry: Business - Services
U.S. Patent for Ovarian Cancer Vaccine Issued; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: ANIXA BIOSCIENCES INC
Industry: Business - Services
Breast Cancer Vaccine Trial to Start Soon; F2Q21 Results; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: ANIXA BIOSCIENCES INC
Industry: Business - Services
Ovarian Cancer Vaccine Obtains Government Award; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: ANIXA BIOSCIENCES INC
Industry: Business - Services
FDA Clarifies Information Requested for CAR-T IND Application; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: ANIXA BIOSCIENCES INC
Industry: Business - Services
FDA Requests Additional Information for CAR-T Therapy IND; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: ANIXA BIOSCIENCES INC
Industry: Business - Services
A Trailblazer in Cancer Vaccines and CAR-T; Initiate at Buy and $11 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y